Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies-Reference-Cited by-同舟云学术

Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies

Published:2008-04-15 Issue:5 Volume:49 Page:845-852
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Garsi Jérôme-Philippe,Schlumberger Martin,Rubino Carole,Ricard Marcel,Labbé Martine,Ceccarelli Claudia,Schvartz Claire,Henri-Amar Michel,Bardet Stéphane,de Vathaire Florent

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference28 articles.

1. Choice of Therapy in Young Adults with Hyperthyroidism of Graves' Disease

2. Loevinger R, Budinger TF, Watson EE. MIRD Primer. Reston, VA: Society of Nuclear Medicine; 1999.

3. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring

4. Zum genetischen Risiko nach hochdosierter Radiojodtherapie unter Berücksichtigung der Gonadendosis

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Cancer Survivorship: Challenges and Opportunities;Endocrine Practice;2024-08

2. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

3. The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health;Seminars in Nuclear Medicine;2024-03

4. Landmark Discoveries in Maternal–Fetal Thyroid Disease Over the Past Century;Thyroid;2023-05-01

5. Risk of Adverse Pregnancy Outcomes in Young Women with Thyroid Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-05-12